Literature DB >> 8005220

Subtyping of Mycobacterium avium complex (MAC) isolates by thin-layer chromatography--distribution of subtypes from patients with AIDS compared with clinically non-significant isolates.

W Chew1, T C Sorrell, G L Gilbert.   

Abstract

Thin-layer chromatography (TLC) was compared with seroagglutination for subtyping of Mycobacterium avium complex (MAC) bacteria. Seventy-five significant MAC isolates from patients with AIDS were typed by both methods and 36 isolates, judged to be clinically non-significant, were examined by TLC only. Overall, 75% of isolates tested were typable by seroagglutination and 91% by TLC; the results correlated between the two except for minor discrepancies. Serovars 1, 8 and 21 and mixed serovars 1-21 and 1-8-21 were common among isolates from AIDS patients and together represented 83% of isolates compared with only 36% in the non-significant group (odds ratio 8.4; 95% confidence interval 3.4-23.3). This difference remained significant after exclusion of serovar 41 (M. scrofulaceum), which was the commonest isolate (28%) in the non-significant group but was not isolated from patients with AIDS. TLC is useful to supplement seroagglutination for subtyping of MAC. Further study is required to determine whether apparent differences between isolates from patients with AIDS and from other sources reflect differences in virulence or in environmental prevalence of MAC subtypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005220      PMCID: PMC2271518          DOI: 10.1017/s0950268800051244

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Mycobacterium avium-intracellulare serovars in German AIDS patients.

Authors:  B Ruf; M Peters; H J Schröder; H D Pohle
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

2.  AIDS and Mycobacterium avium serovars in Sweden.

Authors:  S E Hoffner; B Petrini; P J Brennan; A Y Tsang; G Källenius
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

3.  Association of plasmids and virulence of Mycobacterium avium complex.

Authors:  P R Gangadharam; V K Perumal; J T Crawford; J H Bates
Journal:  Am Rev Respir Dis       Date:  1988-01

4.  Epidemiology of infection by nontuberculous mycobacteria. I. Geographic distribution in the eastern United States.

Authors:  J O Falkinham; B C Parker; H Gruft
Journal:  Am Rev Respir Dis       Date:  1980-06

Review 5.  Mycobacterial diseases other than tuberculosis.

Authors:  E Wolinsky
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

6.  DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients.

Authors:  S J Hampson; F Portaels; J Thompson; E P Green; M T Moss; J Hermon-Taylor; J J McFadden
Journal:  Lancet       Date:  1989-01-14       Impact factor: 79.321

Review 7.  Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

Authors:  L S Young; C B Inderlied; O G Berlin; M S Gottlieb
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

8.  Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.

Authors:  C R Horsburgh; D L Cohn; R B Roberts; H Masur; R A Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

9.  Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum.

Authors:  P S Meissner; J O Falkinham
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

10.  Concentration of Mycobacterium avium by hospital hot water systems.

Authors:  G C du Moulin; K D Stottmeier; P A Pelletier; A Y Tsang; J Hedley-Whyte
Journal:  JAMA       Date:  1988-09-16       Impact factor: 56.272

View more
  1 in total

1.  Genetic characterization of Mycobacterium avium isolates recovered from humans and animals in Australia.

Authors:  M M Feizabadi; I D Robertson; D V Cousins; D Dawson; W Chew; G L Gilbert; D J Hampson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.